HepaGam B

hepatitis B immune globulin · Cangene Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HepaGam B, covering 2013-11-01 to 2015-09-28. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients [Phase 4]